Seminars

Diseases that arise from misfolding of an individual protein are rare. However, collectively, these folding diseases represent a large proportion of hereditary and acquired disorders. In fact, the term "Molecular Medicine" was coined by Linus Pauling in conjunction with the study of a folding disease, i.e. sickle cell anemia. In the past decade, we have witnessed an exponential growth in the number of mutations, which have been identified in genes encoding solute carriers (SLC). A sizable faction - presumably the majority - of these mutations result in misfolding of the encoded protein. While studying the export of the GABA transporter (SLC6A1) and of the serotonin transporter (SLC6A4), from the endoplasmic reticulum (ER), we discovered by serendipity that some ligands can correct the folding defect imparted by point mutations. These bind to the inward facing state. The most effective compound is noribogaine, the metabolite of ibogaine (an alkaloid first isolated from the shrub Tabernanthe iboga). There are 13 mutations in the human dopamine transporter (DAT, SLC6A3), which give rise to a syndrome of infantile Parkinsonism and dystonia. We capitalized on our insights to explore, if the disease-relevant mutant proteins were amenable to pharmacological correction. Drosopohila melanogaster, which lack the dopamine transporter, are hyperactive and sleepless (fumin in Japanese). Thus, mutated human DAT variants can be introduced into fumin flies. This allows for examining the effect of pharmacochaperones on delivery of DAT to the axonal territory and on restoring sleep. We explored the chemical space populated by variations of the ibogaine structure to identify an analogue (referred to as compound 9b), which was highly effective: compound 9b also restored folding in DAT variants, which were not amenable to rescue by noribogaine. Deficiencies in the human creatine transporter-1 (CrT1, SLC6A8) give rise to a syndrome of intellectual disability and seizures and accounts for 5% of genetically based intellectual disabilities in boys. Point mutations occur, in part, at positions, which are homologous to those of folding-deficient DAT variants. CrT1 lacks the rich pharmacology of monoamine transporters. Nevertheless, our insights are also applicable to rescuing some disease-related variants of CrT1. Finally, the question arises how one can address the folding problem. We propose a two-pronged approach: (i) analyzing the effect of mutations on the transport cycle by electrophysiological recordings; this allows for extracting information on the rates of conformational transitions. The underlying assumption posits that - even when remedied by pharmacochaperoning - folding-deficient mutants must differ in the conformational transitions associated with the transport cycle. (ii) analyzing the effect of mutations on the two components of protein stability, i.e. thermodynamic and kinetic stability. This is expected to provide a glimpse of the energy landscape, which governs the folding trajectory.

Dr. Looger will discuss reagents for tracking Ca2+, membrane potential ("voltage"), glutamate, GABA, acetylcholine, serotonin, dopamine, etc. He will also cover optogenetics tools and methods for correlative light/electron microscopy. They make all tools freely available to everyone and work to get them in the hands of people that have limited resources.

Our research investigates how processes of attention, visual working memory (VWM), and decision-making combine to translate perception into action. Within this framework, the role of VWM is to form stable representations of transient stimulus events that allow them to be identified by a decision process, which we model as a diffusion process. In psychophysical tasks, we find the capacity of VWM is well defined by a sample-size model, which attributes changes in VWM precision with set-size to differences in the number evidence samples recruited to represent stimuli. In the first part of the talk, I review evidence for the sample-size model and highlight the model's strengths: It provides a parameter-free characterization of the set-size effect; it has plausible neural and cognitive interpretations; an attention-weighted version of the model accounts for the power-law of VWM, and it accounts for the selective updating of VWM in multiple-look experiments. In the second part of the talk, I provide a characterization of the theoretical relationship between two-choice and continuous-outcome decision tasks using the circular diffusion model, highlighting their common features. I describe recent work characterizing the joint distributions of decision outcomes and response times in continuous-outcome tasks using the circular diffusion model and show that the model can clearly distinguish variable-precision and simple mixture models of the evidence entering the decision process. The ability to distinguish these kinds of processes is central to current VWM studies.

Remarkable advances in experimental neuroscience now enable us to simultaneously observe the activity of many neurons, thereby providing an opportunity to understand how the moment by moment collective dynamics of the brain instantiates learning and cognition. However, efficiently extracting such a conceptual understanding from large, high dimensional neural datasets requires concomitant advances in theoretically driven experimental design, data analysis, and neural circuit modeling. We will discuss how the modern frameworks of high dimensional statistics and deep learning can aid us in this process. In particular we will discuss: (1) how unsupervised tensor component analysis and time warping can extract unbiased and interpretable descriptions of how rapid single trial circuit dynamics change slowly over many trials to mediate learning; (2) how to tradeoff very different experimental resources, like numbers of recorded neurons and trials to accurately discover the structure of collective dynamics and information in the brain, even without spike sorting; (3) deep learning models that accurately capture the retina’s response to natural scenes as well as its internal structure and function; (4) algorithmic approaches for simplifying deep network models of perception; (5) optimality approaches to explain cell-type diversity in the first steps of vision in the retina.

The establishment of effective therapies for neurodegenerative and neuropsychiatric diseases is still challenging and one of the reasons is that especially for age-associated neurodegenerative diseases pathology accumulates long before there are any clinical signs of disease. Thus, patients are often only diagnosed at an already advanced state of molecular pathology, when causative therapies fail. Thus, there is an urgent need for molecular biomarkers that could detect individuals at risk for developing a CNS disease and stratify patients. I will address epigenetic processes such as histone-modifications and non-coding RNAs as potential approaches for patient stratification and therapeutic interaction, with a specific focus on RNA-therapies. Here, I plan to cover examples from our recent research on Alzheimer’s disease and Schizophrenia.

The successful recognition of familiar persons is critical for social interactions. Despite extensive research on the neural representations of familiar faces, we know little about how such representations unfold as someone becomes familiar. In three EEG experiments, we elucidated how representations of face familiarity and identity emerge from different qualities of familiarization: brief perceptual exposure (Experiment 1), extensive media familiarization (Experiment 2) and real-life personal familiarization (Experiment 3). Time-resolved representational similarity analysis revealed that familiarization quality has a profound impact on representations of face familiarity: they were strongly visible after personal familiarization, weaker after media familiarization, and absent after perceptual familiarization. Across all experiments, we found no enhancement of face identity representation, suggesting that familiarity and identity representations emerge independently during face familiarization. Our results emphasize the importance of extensive, real-life familiarization for the emergence of robust face familiarity representations, constraining models of face perception and recognition memory.

New memories are initially labile and have to be consolidated into stable long-term representations. Current theories assume that this is supported by a shift in the neural substrate that supports the memory, away from rapidly plastic hippocampal networks towards more stable representations in the neocortex. Rehearsal, i.e. repeated activation of the neural circuits that store a memory, is thought to crucially contribute to the formation of neocortical long-term memory representations. This may either be achieved by repeated study during wakefulness or by a covert reactivation of memory traces during offline periods, such as quiet rest or sleep. My research investigates memory consolidation in the human brain with multivariate decoding of neural processing and non-invasive in-vivo imaging of microstructural plasticity. Using pattern classification on recordings of electrical brain activity, I show that we spontaneously reprocess memories during offline periods in both sleep and wakefulness, and that this reactivation benefits memory retention. In related work, we demonstrate that active rehearsal of learning material during wakefulness can facilitate rapid systems consolidation, leading to an immediate formation of lasting memory engrams in the neocortex. These representations satisfy general mnemonic criteria and cannot only be imaged with fMRI while memories are actively processed but can also be observed with diffusion-weighted imaging when the traces lie dormant. Importantly, sleep seems to hold a crucial role in stabilizing the changes in the contribution of memory systems initiated by rehearsal during wakefulness, indicating that online and offline reactivation might jointly contribute to forming long-term memories. Characterizing the covert processes that decide whether, and in which ways, our brains store new information is crucial to our understanding of memory formation. Directly imaging consolidation thus opens great opportunities for memory research.

Repeat-rich sequence blocks are considered major determinants for 3D folding and structural genome organization in the cell nucleus in all higher eukaryotes. Here, we discuss how megabase-scale chromatin domain and chromosomal compartment organization in adult mouse cerebral cortex is linked, in highly cell type-specific fashion, to multiple retrotransposon superfamilies which comprise the vast majority of mobile DNA elements in the murine genome. We show that neuronal megadomain architectures include an evolutionarily adaptive heterochromatic organization which, upon perturbation, unleashes proviruses from the Long Terminal Repeat (LTR) Endogenous Retrovirus family that exhibit strong tropism in mature neurons. Furthermore, we mapped, in the human brain, cell type-specific genomic integration patterns of the human pathogen and exogenous retrovirus, HIV, together with changes in genome organization and function of the HIV infected brain. Our work highlights the critical importance of chromosomal conformations and the ‘spatial genome’ for neuron- and glia-specific regulatory mechanisms and defenses aimed at exogenous and endogenous retrotransposons in the brain

Microglia are implicated in a variety of functions in the central nervous system, ranging from shaping neural circuits during early brain development, to surveying the brain parenchyma, and providing trophic support to neurons across the entire lifespan. In neurodegeneration, microglia have been considered for long time mere bystanders, accompanying and worsening neuronal damage. However, recent evidence indicates that microglia can causally contribute to neurodegenerative diseases, and that their dysfunction can even be at the origin of the pathology. In fact, the broad range of physiological roles microglia play in the healthy brain suggest that faulty microglia can initiate neurodegeneration through several possible mechanisms. In particular, in this seminar, we will discuss how dysfunctional microglia can affect synaptic function leading to pathological synapse loss, thus putting microglia center stage in the pathogenesis of brain disorders.

The cortical algorithm hypothesis states that there is one common computational framework to solve diverse cognitive problems such as vision, voice recognition and motion control. In my talk, I propose a strategy to guide the search for this algorithm and I present a few ideas on how some of its components might look like. I'll explain why a highly interdisciplinary approach is needed from neuroscience, computer science, mathematics and physics to make further progress in this important question.

In this lecture, I will present our recent progress on three aspects of population responses in the primary visual cortex: encoding local stimulus attributes, electrical microstimulation and higher visual function. In the first part I will focus on population encoding and reconstruction of contour shapes in V1 and the comparison between monkey and mouse visual responses. In the second part of the talk I will present the effects of microstimulation on neural population in V1 and the relation to evoked saccades. In the final part of the talk I will discuss top-down influences in V1 and their relation to higher visual functions.

Evolution has shaped neural circuits in a very specific manner, slowly and aimlessly incorporating computational innovations that increased the chances to survive and reproduce of the newly born species. The discoveries done by the Evolutionary Developmental (Evo-Devo) biology field during the last decades have been crucial for our understanding of the gradual emergence of such innovations. In turn, Computational Neuroscience practitioners modeling the brain are becoming increasingly aware of the need to build models that incorporate these innovations to replicate the computational strategies used by the brain to solve a given task. The goal of this workshop is to bring together experts from Systems and Computational Neuroscience, Machine Learning and the Evo-Devo field to discuss if and how knowing the evolutionary history of neural circuits can help us understand the way the brain works, as well as the relative importance of learned VS innate neural mechanisms.